ImpriMed

ImpriMed specializes in providing personalized prediction profiles for the treatment of canine and feline lymphoma and leukemia. Utilizing AI-driven drug response predictions, ImpriMed helps veterinarians make informed treatment decisions. The company offers a comprehensive diagnostic service that includes Flow Cytometry and PCR for Antigen Receptor Rearrangement (PARR). ImpriMed has developed a proprietary transport medium to keep cancer cells healthy during shipping and collaborates with over 250 hospitals to collect real-world clinical evidence. To date, ImpriMed has processed over 17,000 canine and feline lymphoma tests using a high-throughput ex vivo drug sensitivity testing platform to analyze live cancer cells. Their Personalized Prediction Profile includes predictions for 13 commonly used anticancer drugs. Additionally, ImpriMed offers customizable CRO services for drug candidates targeting human acute myeloid leukemia, non-Hodgkin lymphoma, or blood cancers in companion animals. Their laboratory is accredited by A2LA for Canine Lymphoma/Leukemia Clonality Testing by PARR and Immunophenotyping by Flow Cytometry. ImpriMed actively participates in various veterinary and medical conferences to showcase their research and advancements. They provide a Vet Portal for veterinarians to order services, track progress, and access test results. The company also hosts the Veterinary Cancer Pioneers Podcast, featuring discussions on advancements in veterinary oncology. ImpriMed’s dedicated team of experts in AI and veterinary medicine ensures accurate and reliable predictions. They offer competitive pricing and fast turnaround times, typically within 3-7 days after receipt of the sample. ImpriMed maintains a high customer satisfaction rate, with 96% of doctors satisfied with their service quality. Their range of services includes Personalized Prediction Profile, Immunoprofile, Flow Cytometry, PARR, and Multidrug Sensitivity Genotyping (MDR1). Additionally, ImpriMed provides educational resources and guides for pet parents on topics such as canine and feline lymphoma, chemotherapy protocols, and treatment options.